Athira Pharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
LITTON MARK JAMES officer: Chief Operating Officer
 Stock Option (Right to Buy) 50,440 $1.35 $68,094
Option
MOEBIUS HANS
Common Stock 28,372 N/A N/A
Option
MOEBIUS HANS
Stock Option (Right to Buy) 28,372 N/A N/A
Option
MOEBIUS HANS
Common Stock 28,372 $1.35 $38,302
Option
MILESON GLENNA
Common Stock 6,305 N/A N/A
Option
MILESON GLENNA
Stock Option (Right to Buy) 6,305 N/A N/A
Option
CHURCH KEVIN
Common Stock 3,152 $1.04 $3,278
Option
CHURCH KEVIN
Stock Option (Right to Buy) 3,152 $1.04 $3,278
Option
CHURCH KEVIN
Common Stock 6,304 $1.04 $6,556
Option
FLUKE JOHN M JR director
 Stock Option (Right to Buy) 25,220 N/A N/A
Option
FLUKE JOHN M JR director
 Common Stock 29,003 N/A N/A
Option
FLUKE JOHN M JR director
 Common Stock 29,003 $1.27 $36,834
Purchase
PERCEPTIVE ADVISORS LLC director, 10 percent owner
 Common Stock 311,111 N/A N/A
Purchase
EDELMAN JOSEPH director, 10 percent owner
 Common Stock 1,058,824 N/A N/A
Purchase
PERCEPTIVE ADVISORS LLC director, 10 percent owner
 Common Stock 1,058,824 N/A N/A
Purchase
RTW INVESTMENTS, LP 10 percent owner
 Common Stock 750,000 N/A N/A

Showing 50 to 66 of 66 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: